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THE presence and activity of the milk-borne agent of mammary tumours of
mice discoveredbyBittner (1936) are detectable only bythe growth ofa mammary
tumour. No other criterion of its presence is yet generally accepted, though an
opinion is widely held that certain localized nodular adenomatous mammary
hyperplasias are an expression ofthe combined activity ofthe milk-borne tumour
agent and a mammogenic hormone. Focal or nodular adenomatous hyper-
plasias in the mammae of dealer's mice were first described by Apolant (1906)
and their cause investigated by Haaland (1911). Haaland inquired but failed
to decide whether the nodules (Fig. 1 and 2) were tumours from the beginning,
or whether they were the basis from which tumours develop. Similar nodules
occur in some inbred strains of mice. Thus Gardner, Strong and Smith (1939)
found their incidence to be greatest in mice of the high cancer strains D and
C3H, and intermediate in the low mammary tumour strain CBA and high mam-
mary tumour strain A. Objections to accepting nodular hyperplasia as evidence
of activity of the milk-borne tumour agent derive from two sources. In the
first place these nodules-have occasionally been found in strains that do not
develop mammary tumours. Gardner et al. found two nodules in one mouse
out of nine of the N strain in which mammary tumours had never occurred.
Also when efforts have been made to exclude the milk-borne agent from high
cancer strains by cross-suckling, nodules have nevertheless been found. Thus
Bittner, Huesby, Visscher, Ball and Smith (1944) examined the mammae of
fostered breeding females (fostered by cancer-free maternal stock) from high
cancer strains A and C3H. All the females had given birth to at least three
litters and ranged from 11 to 16 months old, thereby providing suitable con-
ditions for pathogenic activity of the milk-borne agent. Nodules were found
occasionally, though never more than one to a gland, Thus nodules were still
present though in smaller numbers when efforts were made to exclude them
than in mice which had been suckled on their own cancer-prone mothers. This
evidence indicated that nodule incidence is not eliminated by cross suckling with
the same regularity that is attainable in regard to tumour incidence. Huesby
and Bittner (1946) record that they found no nodules in the mammae of 6 virgin,
and X per gland in 5 out of 12 breeding Zb females; none in 6 virgin and X per
gland in one out of 12 breeding Strong AX females; none in 10 hybrid virgin
females and per gland in 2 breeding females of the F.1 generation derived from
these two strains, both deprived, previous to crossing, of the milk-borne agent.B. D. PULLINGER
They state also that only 7 nodules were encountered in 197 glands of 51 animals
that were genetically susceptible to and had sufficient hormonal stimulation for
mammary carcinoma, but did not develop it because of the absence of the milk
influence. It seems that a possible reduction in the amount of the milk-borne
tumour agent within a strain has to be taken into consideration as well as com-
plete absence. The necessity then arises for scrutinizing every mammary gland.
More recent data derived from control observations to experiments on the
induction of mammary nodules by methylcholanthrene in the absence of the
milk agent (Kirschbaum, Williams and Bittner, 1946) suggest that the first
objection may have been overcome to some extent. These authors give in
their Table I particulars of nodule incidence or absence in three inbred strains.
Their Zb subline lacking the milk-borne agent was derived from the high mam-
mary cancer line Z (identical with C3H, Bittner et al., 1944) by cross suckling.
The mammaryglands of 123 breeding females from this Zb subline were found
to be free of hyperplastic nodules. None were found in 90 C57 (black) nor in
60 NH breeding females. Neither the subline nor these last two mammary
cancer-free strains had developed any mammary tumours in the course of
breeding. If all the mammae of the Zb subline were examined by the authors,
FIG.1.-Spontaneous nodular hyperplasia in a mammary gland of a virgin female mouse
aged 14 months. x 3.
FIG. 2.-Spontaneous nodular hyperplasia in a mammary gland of a virgin female R3 mouse
(carrying the milk-borne agent), aged 13 months. x 14.
FIG. 3.-Hyperplasia induced with 400 Y oestrone in one dose in a spayed R3X virgin female
(lacking the milk-borne agent). x 7.
FiG. 4.-Hyperplasia and cystic distension induced by 800 Y ofa-oestradiol in two doses
in a spayed R3X virgin female (lacking the milk-borne agent). Note tendency to nodular
shape. x 14.
FIG. 5.-Complete regression of hyperplasia induced by 800 Y oestradiol in spayed R3X
female (lacking the milk-borne agent) at 6 months old. X 4.
FIG. 6.-Regression of hyperplasia induced by 800 Y oestradiol in spayed R3 female (carrying
the milk-borne agent), and persistence of areas of nodular hyperplasia (adenomas) at 6
months old. X 4.
FIG. 7.-Early response in a mammary gland of a spayed virgin female mongrel mouse to
800 Y oestradiol, typical also of C57 and Strong A strains. 4.
FIG. '8.-Early response in a mammary gland of an F.1 hybrid spayed virgin female of
C57 x R3X (lacking the milk-borne agent). Note focal hyperplasia in part only of the
gland. x 4.
FIG. 9.-Incomplete involution at edges of a mammary gland in a spayed R3X virgin female,
aged 6 months, after the same treatment as mice in Fig. 5 and 6. x 4.
FIG.10.-Incomplete involution shown by "ghost" acini in a mammary gland of a male
mouse 5 months after hormone stimulation. (See Table II.) x 4.
FIG. 11.-Secondary foci of proliferation in an adenoma forced into activity by oestrogen
in a spayed R3 virgin female mouse, aged 6 months. 7.
FIG. 12.-Secondary focus of proliferation in an adenoma forced into activity in an R3 male
mouse, aged 6 months. X 7.
FIG. 13.-Nodular hyperplasia in a mammary gland 9 weeks after spaying an R3 virgin
female and after the first of two doses of oestradiol, showing the combined response to
hormone and agent. x 7.
FIG. 14.-Nodular hyperplasia in a mammary gland 3 weeks after spaying an R3 virgin
female and treating with 200 Y oestrone, showing combined response to hormone and
agent. X 4.
All figures are microphotographs of mouse mammae stained in bulk in dilute haematoxylin
and mounted in bulk.
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there were 1,230 mammae without hyperplastic nodules. This may have been
due to a more successful transfer of young mice at the time of cross suckling than
in the previous experiment, or to some cause for which we have not at present
got the clue. The former discrepant results (Bittner et al., 1944; Huesby and
Bittner, 1946) have to be remembered, although subsequent observations
(Kirschbaum et al., 1946) provide convincing evidence that hyperplastic mam-
mary nodules do not occur in the absence of the milk-borne tumour agent.
The second source of objection to accepting nodular hyperplasia as evidence
of activity of the milk-borne agent acting alone is that certain observations,
which will be referred to again later, suggest that similar cellular proliferations
with acinus formation are stimulated by oestrogenic hormones alone.
The problem of the exact origin of the hyperplastic nodules is of great
importance for several reasons. These focal acinar proliferations precede malig-
nant tumours in time of appearance and are often more numerous. They might
thus provide an alternative and earlier means of detecting activity ofthe tumour
agent. They may also represent the earliest sign of tumour growth before it
can be described as malignant. If so they would provide material enabling one
to determine which influences are causative and which are encouraging, in the
sense in which the term is used by Rous and Kidd (1941) and Mackenzie and
Rous (1941) in the development ofmalignant tumours. They would undoubtedly
also provide a test in any mnethod devised for analysing the factors which favour
initial pathogenic action ofthe agent. The discrepant results (previously referred
to) concerning their incidence often suggest that they may be more sensitive
criteria of the presence of the agent. If the nodular hyperplasias are to be used
for any of the purposes suggested, it must be proved beyond question that they
are in fact dependent for their origin and continued existence on the presence
of the milk-borne tumour agent, and that the nodules, or some of them, are but
an early stage of eventual malignant tumours. Other possible causes of focal
cell proliferation such as hormones must be excluded. The possibility has also
to be considered that mice of high cancer strains carry more than one formative
milk-borne stimulus for the mammary gland. One agent might be the cause of
frankly malignant tumours and another the cause of nodular hyperplasias. It
appears more probable, however, that one and the same agent is responsible for
both types of tumour, benign and malignant, but that its virulence varies.
Greater virulence would be understood as the capacity to stimulate the mammary
gland cells to multiply and invade or metastasize within the life of the mouse;
less virulent variants would cause merely focal proliferations. The assumption
has been made for present purposes that only one milk-borne formative stimulus
for the mammary gland is transmitted by mice. Whether the cell proliferations
which it produces are benign or malignant depends upon the combination of
its "virulence " with encouraging or deterrent forces.
The experiments here recorded are concerned only with the origin, provoca-
tion and continued existence of the adenomatous hyperplastic nodules. It
was found possible to stimulate the appearance of nodules artificially with
measured limited amounts of hormone at an earlier date than that at which
they become detectable spontaneously. It was also possible to distinguish
responses in the mammary gland due to hormone alone. Responses to other
formative stimuli were considered.
Mamnmae of female and rudimentary mammae of male mice respond to
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two known classes of formative stimuli in adult life at a time when embryological
impulses have ceased to act. These two known classes are firstly, sex hormones,
both natural and synthetic, and secondly, a milk-borne tumour agent having the
general characters of a virus (Bittner, 1945, and Andervont, 1945). Other
formative impulses capable of acting on the mammary gland probably exist in
nature. Carcinogenic hydrocarbons have been found under certain conditions
to induce mammary tumours in the absence of the milk-borne tumour agent as
judged by the absence of palpable mammary tumours in the control groups of
mice (Shimkin, 1945), a criterion which must now be called in question as the
sole evidence of presence of the agent. Hyperplastic nodules undergoing meta-
plasia were found by Kirschbaum et al. (1946) after treatment with methyl-
cholanthrene in the absence of the agent as judged by the absence of nodules in
untreated controls. Local damage to mammary epithelium leading to regenera-
tion is also a stimulus to proliferation (Coen, 1888). There may be others, for
example "chronic irritation," though Haaland (1911) and Woglom (1945), who
sought by observation and experiment respectively to reveal such a cause, were
both unable to do so.
A prelimminary step was required to find whether oestrogenic hormone alone
(in the entire absence of milk-borne agent) is able to stimulate focal or nodular
hyperplasia similar to or distinguishable from that due to the agent, and whether,
if it occurs, such hyperplasia is capable of persisting in the absence of hormone
or other formative stimulus.
It is impossible to solve the problems as they are related to the milk-borne
tumour agent in the entire absence of hormone, because the agent requires the
presence of hormone to become active in respect of tumour cell proliferation
(Lathrop and Loeb, 1916; Shimkin, 1945).
In order to determine the action of hormone alone it was advisable to use
mice as much alike as possible. The inbred strains were tested on the assump-
tion that the mammary gland response of a physiological kind or quality would
be more likely to be similar within a strain than would the responses of a number
of outbred stock mice. The opinion has been expressed and some data relating
to male mice provided in support of it that mammae of various strains respond
differently to oestrogenic hormones in respect of acinus development (Lacassagne,
1934; Gardner, Diddle, Allen and Strong, 1934; Gardner, Smith and Strong,
1935; Burrows, 1936; Bonser, 1936). The results of these authors indicated
also that acinus formation was an occasional feature only, and was independent
of any association with proneness to mammary cancer (Burrows, 1945). Varia-
tion in anatomical structure of the mammary glands of different strains has been
reported by v. Gulick and Kortoweg (1940). A difference, which is inherited,
in susceptibility to pathogenic activity of the milk-borne tumour agent exists
in inbred strains (Bittner, 1939; 1943). For all these reasons it was necessary
to assume and seek for a strain difference. Strains examined for response to
hormone alone were R3X* males and females deprived of the agent by cross
suckling; C57 (black) females; Strong AX females and males; Simpson
females. The last are an inbred strain in which pure line breeding has been
once interrupted since 1937 and replacedby mating of distantly related progeny.
Though derived from an original strain with a high incidence of mammary
* An X after a mouse strain indicates in this that the strain had been freed from the
milk-borne tumour agent.
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cancer, 'breeding females have never developed mammary cancer in these
laboratories.
Before testing the high cancer line R3, sublines deprived of the milk-borne
tumour agent were bred. Strong AX sublines have been maintained in these
laboratories since 1942. Milk-borne tumour agent had to be excluded because
the presence ofthis second formative agent might confuse results due to responses
to hormones alone. All the virgin females tested were segregated from males
at the time of weaning (3 to 4 weeks old), and were spayed between the 49th
and 56th days ofage. These steps were taken to avoid changes due to pregnancy
or pseudo-pregnancy, and to have in action, so far as possible, known measured
doses of hormone. The same procedure excluded changes due to failure of
involution of lactating or partially stimulated mammary glands. The responses
to single and repeated doses' of ovarian hormones were examined at various
intervals after application as described under experimental methods.
The existence of a strain difference in response to oestrogens which was
independent of the presence of milk-borne tumour agent was confirmed. The
response was atypical in R3X and Simpson mice and will be described in more
detail under results. Focal hyperplasia of acini was found widespread in all
the R3X and Simpson mammae after treatment with the oestrogens, oestradiol
and oestrone (Fig. 3 and 4). It did not persist indefinitely in the absence of the
hormone. A similar response was obtained in R3 mice (containing the milk-
borne tumour agent), but while the hormone conditioned response regressed
and finally disappeared in the absence of further artificial stimulation in spayed
mice, there remained in these mammae irregularly scattered areas offocal nodular
hyperplasia which did persist in the absence of further hormonal stimulation
(Fig. 5 and 6). Both in their origin and continued existence these nodules are
considered to have been caused by the milk-borne tumour agent, though their
origin was conditional on the presence of the hormone. They will subsequently
be referred to as adenomas. A similar hormonal response was obtained in
C3H mice giving rise to focal hyperplasias, but as this strain was not freed from
the milk-borne tumour agent, it is uncertain, though probable, that the response
to hormone alone would have given this atypical reaction. The C3H mice
also developed adenomas which were maintained in existence when no further
ovarian hormone was being supplied, and no evidence of any. naturally secreted
oestrogen was obtained from vaginal smears. A few other strains were examined
(Table III).
EXPERIMENTAL METHODS.
Choice of mice.
Inbred R3 (Paris) mice were used. Some were derived from pure lines,
others from random breeding within the strain. The incidence of spontaneous
nodules ofhyperplasia in the mammae in 26 virgin females segregated from males
had previously been found to be 100 per cent after the age of 8 to 9 months.
Malignant tumour incidence in the same series was 69 per cent Nodules in
this strain are extremely numerous in both virgin females and breeders.
R3X sublines free from the milk-borne tumour agent were bred by foster
nursing an original family of 2 females and 1 male on a C57 (black) mother from
the moment of birth. From one of these females several sublines were obtained.
All the R3X mice used were the progeny of brother and sister matings. A
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record was kept of the relationships of every mouse of these sublines so that, if
evidence of the presence of milk-borne tumour agent subsequently reappeared,
the progeny liable to be affected could be traced. From every litter containing
more than one female, one or two were used for testing the hormone response
while the remainder were allowed to breed. This breeding provided further
mice for testing, and also controls to prove the absence of the milk-borne agent.
The same breeding females also provided controls for all the male mice that
were treated. Altogether, 44 breeding females reached the average tumour
age (81 months for this strain); ofthese 24 were force bred owing to the circum-
stance that they failed to rear or destroyed their young, a habit to which many
R3 females are prone. In three years no tumours were seen. The average
age at death of the breeding females was 14 months. Two hyperplastic nodules
were seen in two breeding females that failed to rear any litters. No others
were seen in the breeding stock.
01Oerative treatment.
Virgin females were spayed at approximately 56 days old. The exact age
was always known, but not the previous oestrus record, if any. Many R3 and
R3X females were found, by the vaginal smear technique, to have started oestrus
cycles before this time. The treated males varied from 5 to 9 weeks old. Twelve
R3 males were castrated.
After removal of hair with a depilatory from the abdominal surface, the
females were anaesthetized with 0.3 ml. of a 3 per cent suspension in distilled
water of bromethol, except when Strong A mice were to be operated on. The
majority of Strong A mice when two months old or over failed to survive the
combination of this anaesthetic and ovariectomy. Their survival could only
be assured after they had reached the age of 2 months, if ether 'ere used. The
ovaries of all mice were removed by the abdominal route; they were excised
together with about - in. of their oviducts (uterine horns). Successful removal
ofall local oestrogen-producing tissue was judged at autopsy by complete atrophy
of oviducts and uterus. Vaginal smears were made from some of the females
for 2-3 weeks before they were killed. It was necessary to examine the former
site of uterus and oviducts in every mouse, because if the tissues were not excised
as described, cysts containing clear fluid sometimes developed at the cut ends of
oviducts after subsequent oestrogen treatment. When this was the case atrophy
of uterus and oviducts was never complete, and the impression was gained as
the result of much experience of mammary gland changes that these cysts were
themselves secreting oestrogen. This difficulty was soon overcome at a time
when oestrus records were not being made in spayed mice, so the matter was
never settled. When ovariectomy and removal of approximately the upper I in. of oviducts was complete, no cysts were seen at autopsy 16 to 20 weeks
later. The oviducts became very slender tubes (brownish in R3 and R3X mice)
and the uterus was greatly shrunken. Oestrus cycles ceased in all those mice
which were tested and did not reappear. Any mice that had developed intra-
abdominal cysts or ligature abscesses, thereby possibly concealing cysts, at the
cut ends of the oviducts, or whose oviducts had not undergone atrophy at the
16th to 20th weeks of experiment, were discarded. At earlier dates atrophy
may be incomplete, varying in degree with the original dose of hormone.
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Hormone treatment.
In accordance with a recommendation ofMixner and Turner (1943) treatment
of the females with hormone was begun within 24 hours of the spaying (usually
18 hours). A measured dose was delivered from a graduated 0.2 ml. pipette on
to the skin of the whole length of the back after clipping off the hair. The
hormones were dissolved in acetone, a 0.01 per cent solution for the smaller
doses (10--100 Y) and a 0.1 per cent solution for the larger ones (200-800 Y).
The larger doses were delivered to females and males in divided doses over a
period of 2 to 4 hours in hourly applications in the hope thereby of increasing
absorption. For the same reason a final application of acetone alone was given.
The method is recognized as being inaccurate and of comparative value only as
regards quantitative dosage. The purpose in using it was to give a limited
measured amount of hormone within at most a few hours in order to obtain a
limited response rather than a cumulative one due to prolonged irregular absorp-
tion as from oily solutions or pellets. The ideal is a watery solution injected
intravenously, but at the time experiments were begun none was available in
sufficient strength to give large doses.
Preliminary experiments had indicated that two large arbitrarily chosen
doses of oestradiol of 400 microgrammes each applied at 20 days' interval were
effective in stimulating combined pathological activity of milk-borne tumour
agent and hormone. Later experiments showed this dose to be unnecessarily
large for this purpose in R3 mice (See Table I). It was adhered to in the present
TABLE I.-Comparison of State of Involution and Adenoma Incidence in Mammae
in Spayed Virgin Female Mice After Limited Treatment with Oestrogen.
Dosage in microgrammes. Number of mice with N~~~~~~~~~ umber of mice.wt
Mouse a-Oestradiol Oestrone. involution complete at- umber o me Mouse o-Oestradiol. Oestrone.
strain. ~- - With 1st 2nd Single 16 20 28-31 Total. adenomas. sri. dose. dose. dose. _weeks of experiment.
R3 . 400 400 - . 21 1 6 . 28 28
- - 50 . - 9 - . 9 9
- - 30 . 6 - - . 6 1
- - 10 . - 6 - . 6 0
R3X . 400 400 - . 7 out 8 out - . 20 None
of 12 of 8
X after the strain denotes absence of milk-borne Total mammae examined, 690.
tumour agent.
- denotes no test was done.
series of experiments because it seemed adequate and not too large to provoke
similar results in R3 x C57 (F.1) hybrids treated in the same way. It has been
retained as the maximum dose for provoking the agent, and for judging and
comparing hormone response alone in different strains and hybrids. Experi-
ments using a descending scale of dosage are in progress. The results indicate
that responses in females vary quantitatively with dosage and qualitatively
with strain and, within the strains, with ages younger than 49 to 56 days old.
For the purpose of the present experiment most of the females received two
doses of 400 microgrammes at 20 days' interval. Some of the males were treated
with three doses ofoestrogen and one ofprogesterone (see Table II), on anassump-
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TABLE II.-Comparison of State of Involution and Adenoma Incidence in Mammae
ofMale Mice After Limited Treatment with Ovarian Hormones.
Dose of oestrogen* inumber of mice Number of
Mouserai microgrammes. Dose of withinvolution mice. Moustrain. progesterone in Complete at- strain. ~'--"-'~ ~ With 1st 2nd 3rd microgrammes. 2 Tal ith
doe ose. doe24 8 Tta.adenomas. dose. dose, dose. weeks of experiment.
R3 . 400 400 400 . 1,500 . 5 25 . 30 28
400 400 400 . - . 10 - . 10 10
400 400 . - . 11 - . 11 4
R3X 400 400 400
400 400 400
1,500
10
X after the strain denotes absence of milk-borne
tumour agent.
- denotes that no test was done.
* oc-oestradiol or ketohydroxyoestrin.
t 6 contained ghost acini (see Fig. 10).
18t . 18 None
5 . 15 None
Total fat pads examined,
840.
tion which proved to be incorrect so far as the R3 strain is concerned-that the
progesterone would be required to bring about lobular-alveolar development
in male mammae. It did, however, aid mammary outgrowth and differentiation
probably in the way indicated by Mixner and Turner (1943). Details of oestro-
gens and dosage are given in Tables I, II and III.
TABLE III.-Preliminary Test ofEarly and Late Responses to
Oestrogen in Other Strains ofFemale Mice.
Strain.
C3H
Strong A
Simpson
C57 (black)° .
C57 x R3X F.1
R3 x C57F.1 .
Mongrels (Liverpool)
Dosage of oes
in micrograr
1st
dose.
400
400
400
400
400
400
400
tradiol
nimes.
2nd
dose.
Early response.
400 . Lobular-alveolar (patchy)
400 . Normal
400 . Lobular-alveolar (widespread)
400 . Normal
400 . Halfgland normal; half
lobular-alveolar (Fig. 8)
400 .
400 . Normal in 2 mice; lobular-
alveolar (widespread in 1;
focal in 7)
Late result at 16 to
20 weeks.
Total Number with
mice. adenomas.
10 10
10 None
7 None
27 None
19 20
indicates no observation was made.
Examination of mammac.
Mammae were examined after the first or second application of hormone at
intervals which varied according to the purpose ofthe experiment. All mammae
were dissected out and fixed fiat together with the skin on sheet cork. In several
mice responses were observed also in vivo. This is possible because in R3 and
R3X females the large double dose (800 microgrammes) invariably stimulated
the 2nd mammary glands to grow out into the interscapular fat on the back.
This was seen in 15 out of 15 R3X females. If mice which have been treated
with oestrogen at 20 days' interval are anaesthetized 4 days to 3 weeks after the
second dose and a small incision is made in the mid line, it is possible to see this
response with the naked eye, with a loupe or magnified a few times with a
184MILK-BORNE AGENT OF MAMMARY ADENOMAS IN MICE
binocular dissecting microscope after parting the cut edges of skin by gentle
blunt dissection. Of the.strains examined only R3, R3X and Simpson females
have been found to grow out regularly in this way. The response is visible
owing to its atypical nature in respect of a milky secretion which renders ducts
and clusters of acini visible. Mice examined in vivo in early stages and all
others were finally killed. All 10 mammary glands (or fat pads in males) were
stained in bulk, cleared, inspected, and whole mounts made of representative
mammae or those showing special features.
The method of staining in bulk differed little from that described by Gardner
(1934). After 4 days' fixation in Bouin's fluid the mammae were dissected off
from the skin, muscle and covering fascia with the aid of a dissecting microscope
magnifying 7 and 14 times. Nerve fibres were removed and some of the large
blood vessels. These stripped mammae were then immersed overnight in 50 per
cent alcohol, and next stained for about 4 hours in 1 part of Ehrlich's acid
haematoxylin freshly diluted with 3 parts of a 2 per cent aqueous solution of
acetic acid. After differentiating for about 10 minutes in acid alcohol (3 per
cent HC1 in 50 per cent alcohol) the stained glands were rendered blue or blue-
black in several changes of 50, then 70 per cent alcohol for as many hours or
days as were required to develop a deep colour. They were next dehydrated
and cleared in the usual manner. While in the first change of clearing agent
(xylol) notes were made by the author after examining all 10 mammae or fat
pads with the binocular dissecting microscope. Some were selected for making
permanent mounted preparations and for storage in paraffin. The remainder
were discarded.
RESULTS.
R3X females deprived of their ovaries and of the milk-borne tumour agent.
Twenty days after the application to the skin of 400 microgrammes of keto-
hydroxyoestrin, 0-1 per cent dissolved in acetone, the duct system had grown
out and branched extensively (Fig. 3). The ducts were distended and filled
with milky secretion, which rendered the main branches and many smaller ones
visible to the naked eye in all 10 mammary glands. There was also a pseudo-
lobular alveolar differentiation with great multiplication of acini arranged in
clusters in all 10 mammary glands. The large clusters could also be seen macro-
scopically as milky white lobed structures. Many of the acini composing them
were ballooned out with secretion (Fig. 3). A similar response was given by
the maximum dose of 400 Y of oc-oestradiol repeated at 20 days' interval (total
800 Y) in 15 out of 15 mice which were examined in 'ivo. The most noticeable
difference after the larger dose was outgrowth in every mouse into interscapular
fat pads and possibly more secretion (Fig 4).
These responses are atypical and pathological. They differ from changes in
the normal female mouse in oestrus (Cole, 1933; Turner and Gomez, 1933) and
from responses in normal mice artificially treated with oestrogens (Turner and
Gomez, 1934) in that lobular-alveolar differentiation and secretion occur in
addition to duct outgrowth. Instead of a single response by duct outgrowth,
there is a triple response to the one hormone. It is like a pseudo-pregnancy
response. It is pathological in that it is irregular, distorted by distension
and patchy in distribution within the glands. In extent it did not exceed the
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limits of outgrowth attained during normal pregnancy. It is pathological also
in that the degree of differentiation is suggestive of a 9th-12th day pregnancy
while the milky secretion is voluminous. Male glands reacted to larger doses
in a similar manner. They were often more irregular in arrangement of ducts
and acini. In normal stock mice and in rats also the response of the mammae
to spontaneously secreted or to injected oestrogens is by simple duct outgrowth
(Fig. 7). Lobular-alveolar growth requires the stimulus of pregnancy or of
artificially applied progesterone in addition to oestrogen (Mixner and Turner,
1943). Normal unmated female mice have no luteal phase in the ovarian cycle
and are said to secrete no luteal hormone. The atypical oestrogen response of
R3X and Simpson mice is a hormone conditioned hypertrophy and hyperplasia,
including adenosis and secretion by the glandular cells. That it is atypical, even
among inbred strains, is shown by comparison with C57 (black) and Strong AX
virgin female mammae after identical treatment. No dose of oestrogen was
found that gave a similar response in C57 (black) females or males or in Strong A
or AX females or males. Continued treatment over a long period of time some-
times resulted in slight local acinus formation in Strong A mice. At the age of
one month no response was observed in R3X females save for a tendency of the
end bulbs to canalize.
The minimnum dose of oestrogen required to reveal this capacity for atypical
responses in R3X mice and the time after treatment when it first appears have
not yet been found. This atypical response is the cystic disease of mouse
mammae first described by Haaland (1911) as occurring spontaneously in mixed
stock (though in these animals a milk-borne agent may also have been present),
and later by Gibson (1930) in inbred strains. It was first reproduced experi-
mentally in mixed stock mice in 9 out of 11 spayed females by Goormaghtigh
and Amerlink (1930), who compared it with Reclus disease in the human breast.
Experiments here recorded provide the additional information that the response
can be provoked independently of the presence of milk-borne tumour agent,
and confirm opinions previously expressed that it is a strain characteristic.
It is of interest that in a small series of virgin and breeding R3X females cystic
distension has never been observed to occur spontaneously (in 25 out of 25
examined).
The atypical response might be due either to local differences in sensitivity
of the end bulbs of various strains of mice or to the response in the pituitary
gland, where, according to Gomez and Turner (1937; Gomez, Turner and
Reece, 1937) the effective mammogenic hormones are produced, or to a combined
response in both organs. Some light on this problem was gained from experi-
ments similar to those here described using the double dose of 400 microgrammes
of oestradiol on spayed F. 1 hybrid females of the C57 x R3X cross. The curious
observation was made that a similar lobular-alveolar response was provokedin
all the mammae, but it was localized in approximately half of each gland. The
other half responded typically like the C57 (black) parent's gland (Fig. 8).
These results suggest that the atypical response is due in part at least to variation
inlocal sensitivity of ducts and end bulbs, and not solely to a strain difference in
the pituitary response.
In the absence of ovaries and of any further application of hormone the
characteristic but atypical reaction persisted in R3X mice for about ten weeks
after the beginning of the experiment, using 800 microgrammes of oestradiol.
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Regression of the whole of the recent acinar and pseudo-lobular-alveolar de-
velopment started after about the 10th week, and was complete in most of the
mice between the 16th and 20th week. The mice were then 6 to 7 months old.
The exact time taken for complete regression varied with the degree of the
original response, which in its turn varied slightly in individual mice. Complete
regression was indicated by total disappearance ofall lobules, acini and secretion.
Bare, shrunken, almost linear ducts remained (Fig. 5). Details of the number
of mice examined in this way and of complete or incomplete regression of the
hormone response are given in Table I. Some of the animals killed at 16 weeks
revealed remnants of atrophic pigmented acini usually in small groups at the
periphery of the 4th mammae, probably at the site of former large clusters.
Fig. 9 is representative of these imperfections of involution. Sometimes de-
tached ghost acini remained unabsorbed (Fig. 10). No inflammatory or meta-
plastic nodules were encountered.
In the course of these experiments the possibility had to be considered that
in the females some other sources of oestrogens might be stimulated by ovariec-
tomy and after cessation of the action of artificially applied hormone to produce
oestrogens, as Smith and Bittner (1945) found in the C3H strain. That no such
stimulation had occurred was proved by making vaginal smears during the last
two to three weeks of the experimental period in 11 out of 20 mice, and by
inspection of uterus and oviducts at autopsy. In no case was there a return of
oestrus or failure of uterus and oviducts to atrophy.
R3 Virgin Females Deprived of their Ovaries but Containing the
Milk-borne Tumouqr Agent.
Early changes in the mammae in response to ovariectomy and oestrogen
treatment (ketohydroxyoestrin and oestradiol) were similar to those described
in the same strain deprived of the tumour agent (32 out of 32 mice). Differences
were detectable in the intervening period, but it will be convenient first to con-
trast the final results at 16 to 20 weeks in the two sets of mice. Proliferation
due to hormone action regressed at a similar rate and was complete, so far as
this can be judged in the presence of the tumour agent, at some time between
the 16th and 20th weeks ofexperiment. Regression was expressed in the greater
part of all mammae by disappearance of lobules and alveoli and by the presence
of a shrunken duct system. In the majority of mammae, however, there per-
sisted localized nodular areas ofproliferation of acini on the duct system (Fig. 6).
These were found in all of 28 mice and, in addition, 11 out of 40 mice killed
before the 8th month of life bore mammary adenocarcinomas. The earliest of
these appeared at four-and-a-half months old. The nodules of proliferation
occurred on otherwise atrophic duct systems, giving a picture similar to that described by Gardner et at. (1939). By the vaginal smear technique, oestrus
cells were seen on one occasion in each of 2 mice out of 32 examined. In 30
mice oestrus cycles or cells did not recur.
The contrast between the mammae in the two sets of mice at 16 to 20 weeks
was striking. There was complete absence of adenomas in those mice which
had been deprived of the milk-borne tumour agent, whereas in mice of the
original R3 strains carrying milk agent adenomas were numerous in nearly all
the glands of every mouse. Fig. 5 and 6 are representative of 200 mammae
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from the R3X females and 280 from those carrying the agent. A few imperfec-
tions due to incomplete regression did not cause confusion, and will be referred
to in this connection again.
The conclusions were drawn that the foci of hyperplasia (adenomas) in the
R3 females carrying tumour agent, were due in respect of their origin and per-
sistence to the presence of a milk-borne tumour agent, presumably identical
with or a variant of Bittner's agent, and that this agent had been forced into
activity by the large dose of-hormone. These nodules are considered to be
experimentally produced counterparts of those that occur spontaneously in all
R3 females after the age of 8 to 9 months. They are similar to those described
in great detail, and finely illustrated by Gardner (1942) in other strains. Gardner
demonstrated the persistence of spontaneous pregnancy-activated adenomas in
the absence of further hormone stimulation in hypophysectomized breeder
females. The present experiments provide a simple method of forcibly stimu-
lating adenomas and of revealing their dependence on the milk-borne tumour
agent.
A few more descriptive details that are characteristic of R3 adenomas may
be added to Gardner's comprehensive accounts. Both spontaneous and forcibly
activated R3 adenomas are of two main varieties, compact (Fig. 6) and diffuse
(Fig. 11) clusters of acini connected by shorter or longer lengths of duct. Some
of the former appear to lack duct formation altogether. Some of the latter may
be largely composed of ducts, similar to one of Gardner's, or even of end-bulbs.
Many of the diffuse loosely constructed adenomas contain secondary foci of
more active proliferation (Fig. 11 and 12), indicating perhaps sites of greater
vigour of the stimulating agent, and providing evidence for the existence pre-
viously suggested of variants of the agent. These secondary foci were found
frequently in both spontaneous and artificially activated adenomas, including
many in males treated with hormone. They too were independent of ovarian
hormone for maintenance once they had been activated. No inflammatory or
metaplastic nodules were encountered.
The earliest date at which adenomatous proliferation was found was at 21
days after a single dose of 200 microgrammes of ketohydroxyoestrin (Fig. 14).
This finding was not constant at 21 days. Adenomas were found in 4 out of
4 mice at 9 weeks after 800 microgrammes given in 2 doses of 400 microgrammes
each at 20-day intervals, applied to spayed females at approximately 56 days
old. At these dates the hormonal response in the mammae was still in existence,
and the interpretation ofan adenomatous response was open to question (Fig. 13).
The differentiation between focal hyperplasia or adenosis caused and maintained
by hormone alone and adenomatous nodules caused and maintained by milk-
borne tumour agent plus hormone is possible in some nodules only. In others
no certain decision can be reached. The chief difference in the two kinds of
clusters of acini rests on their spatial arrangement and relative regularity. The
hormone induced hyperplasias tend to lie in one plane; the combined response
of hormone and milk-borne tumour agent is exceedingly irregular in comparison
and lies in all dimensions (Fig. 3 and 13). When, as in one adenomatous nodule
seen at 3 weeks (Fig. 14) numerous end bulbs were observed arising from a cluster
of acini, there can be no doubt of the pathological and atypical origin of the
proliferation due to stimulation other than by hormones. End bulbs, though
sometimes multiple, are normally situated at the tips only of growing ducts
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(Cole, 1933). This is also the case when artificially supplied hormones are
acting alone.
The smallest total dose of oestrogen which constantly activated the milk-
borne tumour agent into pathological activity as shown by adenoma production
was 50 microgrammes of ketohydroxyoestrin given through the skin in a small
series of mice (Table I).
R3X Males Deprived of the Milk-borne Tumour Agent.
The rudiments of mammae of males derived from the same sublines as the
females and treated with larger doses of ovarian hormones responded in a similar
manner. An average of 6 mammary glands per mouse developed from rudi-
ments and all examined revealed the atypical response characteristic of females
of this strain. Irregular lobules were seen after cutaneous application of 800-
1200 microgrammes of oestradiol with or without 1500 microgrammes of pro-
gesterone. Regression required 6 to 7 months to become complete, leaving
bare atrophic ducts (Table II).
R3 Males Containing Milk-borne Tumnour Agent.
When additional time had been allowed for regression of hormone response,
results were similar, and almost as regular as in spayed females containing milk-
borne tumour agent. Either oestrogen alone (1200 microgrammes) or combined
with one dose of progesterone (1,500 microgrammes) was sufficient to stimulate
the growth of adenomas (Table II). Adenomas were found in 38 out of 40
male mice, but were not so numerous in individuals as in the females. Nine of
the males developed malignant tumours by this treatment in 5 months.
Twelve males which were castrated before treatment with hormone de-
veloped adenomas but no malignant tumours. The hormone dosage used was
better tolerated by all the male mice than by the more usual protracted method.
Results were not better in respect of stimulation when progesterone was added
than in experiments in which oestradiol alone was used (Table II) but a larger
number of malignant growths was seen.
Other Varieties of Mice.
The same methods were applied in preliminary tests to C3H, Strong A,
Simpson and C57 (black) strains. Results are summarized in Table III. The
fact that mammae of Strong A females respond normally to oestrogen, that is
by duct outgrowth only, indicates that the atypical pseudo-lobular-alveolar
response probably does not represent a structural basis of the hereditary factor
underlying susceptibility to pathological activity of milk-borne tumour agent.
Since it might be suggested that the lobular-alveolar response is an expression
of a mutation in some highly inbred strains, a few stock mice obtained from a
dealer were examined by the same technique as for hormone response. These
were got from a town where, so far as one knew, no inbreeding of pure lines was
being carried on. This precaution was taken to avoid mice that originated
from pure line laboratory bred strains. One out of 11 of these mongrel mice
responded with early widespread pseudo-lobular-alveolar differentiation and
secretion. In degree the distension and proliferation were less than in some
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ofthe inbred strains, but in distribution and kind the reactions were very similar.
This indicates that if the reaction is based on a mutation, then the mutation can
occur also under relatively natural conditions.
The test for activation of milk-borne tumour agent has been applied to
reciprocal hybrids and the results are incomplete. They indicate so far that
hybrids are suitable experimental material for the present purpose (Table III).
COMMENT.
The work here recorded confirms the opinion already widely held that hyper-
plastic nodules in the mammae of mice provide evidence of pathological activity
of the milk-borne tumour agent, and shows how this activity can be forced and
detected sooner than by the spontaneous appearance of mammary tumours.
The presumption is that the agent provoking nodular hyperplasia and the tumour
agent are the same or of like nature, because in both cases the response is by cell
proliferation. Further work is required to settle the degree of similarity. The
two objections to accepting nodular hyperplasia as evidence of activity of the
agent have been met. The criteria proposed as bases for the validity of the test
were twofold. They required the absence of nodular hyperplasia (adenomas),
and of all other signs of acinus formation in the absence ofthe agent and absence
of hormone. They required the development of adenomas in involuted mammae
in the presence of the agent and absence of hormone. As has been recorded,
perfection in respect of complete absence of acini required in the first criterion
was attained in 15 out of 20 females; in 5 others killed at an earlier date acini
were found which were regarded as being, at the time of death of the mice, in
process of regression. There was, in the authors' opinion, no reasonable possi-
bility of confusing these surviving acini with adenomas. The surviving acini
were grouped along the periphery of the gland (Fig. 9) in a manner bearing no
resemblance to adenomas (Fig. 6). Their shrunken atrophic character was
apparent. It is probable that the provocative doses of hormone were larger
than needed for the purpose, and that given the same time for involution to take
place a smaller dose would have been succeeded by complete disappearance of
acini. Alternatively a longer interval must be allowed for the larger dose.
Regression of hormone response was more often complete in males, probably
owing to the longer time interval allowed for it (Table II). Success in respect
of the second criterion was attained in 28 out of 28 females and in 28 out of
30 males.
SUMMARY.
1. Variations in response to oestrogenic hormones in the mammae of spayed
females of several strains of mice have been confirmed. They have also been
found in mice from a dealer. The variations consist of pseudo-lobular-alveolar
differentiation and secretion of milky fluid in addition to the normal response
of duct outgrowth. The response is a pathological hyperplasia or adenosis of
the mammary gland. It is independent ofthe presence ofthe milk-borne tumour
agent. In the absence of further oestrogenic stimulation in spayed mice this
pseudo-lobular-alveolar response regressed, leaving bare shrunken ducts.
2. A second type of response was elicited in R3 and C3H mice carrying the
milk-borne tumour agent. This second response was identified with certainty as
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caused by the milk-borne tumour agent (Bittner's or a variant of it) only when
all other formative agents were excluded. This was done by spaying and
providing a limited dose of hormone to provoke pathogenic activity of the agent.
It was characterized by the appearance of adenomas in otherwise involuted
mammae. It is suggested that these adenomas are to be regarded as evidence
of activity of milk-borne tumour agent when all other formative agents have
been excluded, whether they occur spontaneously or are forcibly stimulated.
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